Michael WY Chan

484 total citations
13 papers, 391 citations indexed

About

Michael WY Chan is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Michael WY Chan has authored 13 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Michael WY Chan's work include Epigenetics and DNA Methylation (7 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Urinary and Genital Oncology Studies (2 papers). Michael WY Chan is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Urinary and Genital Oncology Studies (2 papers). Michael WY Chan collaborates with scholars based in Taiwan, United States and Hong Kong. Michael WY Chan's co-authors include Hung‐Cheng Lai, Pearlly S. Yan, Jian‐Liang Chou, Hui‐Wen Yang, Chien-Kuo Tai, Huey‐Jen Lin, Shu-Fen Wu, Tim H-M. Huang, Kenneth P. Nephew and Ramana V. Davuluri and has published in prestigious journals such as Molecular Cancer, The Journal of Pathology and BMC Genomics.

In The Last Decade

Michael WY Chan

13 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael WY Chan Taiwan	11	283	81	58	57	35	13	391
Jian Gu China	10	167 0.6×	61 0.8×	78 1.3×	71 1.2×	54 1.5×	20	310
Anal Desai United States	5	268 0.9×	74 0.9×	60 1.0×	53 0.9×	40 1.1×	5	412
Wenwen Sun China	11	169 0.6×	87 1.1×	27 0.5×	56 1.0×	30 0.9×	30	310
Truong Lam United States	9	206 0.7×	58 0.7×	29 0.5×	63 1.1×	74 2.1×	16	390
Pablo García‐Sanz Spain	11	272 1.0×	85 1.0×	32 0.6×	62 1.1×	63 1.8×	12	387
Ting‐Yan Shi China	7	270 1.0×	132 1.6×	33 0.6×	80 1.4×	41 1.2×	10	371
Dongyi Wan China	10	326 1.2×	146 1.8×	26 0.4×	153 2.7×	44 1.3×	16	481
Gregory Miles United States	5	199 0.7×	117 1.4×	28 0.5×	88 1.5×	14 0.4×	5	345
Daniel Onofre Vidal Brazil	13	389 1.4×	226 2.8×	87 1.5×	63 1.1×	76 2.2×	31	530
Jinyu Xiang China	11	266 0.9×	126 1.6×	36 0.6×	94 1.6×	57 1.6×	20	357

Countries citing papers authored by Michael WY Chan

Since Specialization

Citations

This map shows the geographic impact of Michael WY Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael WY Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael WY Chan more than expected).

Fields of papers citing papers by Michael WY Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael WY Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael WY Chan. The network helps show where Michael WY Chan may publish in the future.

Co-authorship network of co-authors of Michael WY Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael WY Chan. A scholar is included among the top collaborators of Michael WY Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael WY Chan. Michael WY Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lee, Shiao‐Pieng, et al.. (2020). Differential DNA methylation profiles of peripheral blood mononuclear cells in allergic asthmatic children following dust mite immunotherapy. Journal of Microbiology Immunology and Infection. 53(6). 986–995. 6 indexed citations

Chen, Lin‐Yu, Rui Huang, Michael WY Chan, et al.. (2019). TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target. The Journal of Pathology. 248(3). 363–376. 29 indexed citations

Lee, Shiao‐Pieng, et al.. (2019). Dendritic cell upregulation of programmed death ligand-1 via DNA demethylation inhibits experimental autoimmune encephalomyelitis. Journal of Autoimmunity. 107. 102362–102362. 11 indexed citations

Chan, Michael WY, et al.. (2017). Dust mite allergen-specific immunotherapy increases IL4 DNA methylation and induces Der p-specific T cell tolerance in children with allergic asthma. Cellular and Molecular Immunology. 15(11). 963–972. 24 indexed citations

Chou, Jian‐Liang, et al.. (2014). Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma. Journal of Translational Medicine. 12(1). 237–237. 22 indexed citations

Shen, Cheng‐Huang, et al.. (2013). The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder. BMC Complementary and Alternative Medicine. 13(1). 44–44. 13 indexed citations

Rodríguez, Blanca, David Frankhouser, Mark W. Murphy, et al.. (2012). Methods for high-throughput MethylCap-Seq data analysis. BMC Genomics. 13(S6). S14–S14. 25 indexed citations

Peng, Zhengang, Zhaosheng Han, Rulong Shen, et al.. (2012). Dichotomy effects of Akt signaling in breast cancer. Molecular Cancer. 11(1). 61–61. 7 indexed citations

Chen, Pi-Che, Yeong‐Chin Jou, Chi‐Fai Ng, et al.. (2011). Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine. BMC Medical Genomics. 4(1). 45–45. 36 indexed citations

10.

Chou, Jian‐Liang, Her‐Young Su, Lin‐Yu Chen, et al.. (2010). Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Laboratory Investigation. 90(3). 414–425. 99 indexed citations

11.

Lai, Hung‐Cheng, et al.. (2010). TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy. Expert Opinion on Therapeutic Targets. 14(11). 1213–1223. 33 indexed citations

12.

Torng, Pao‐Ling, Ching‐Wei Lin, Michael WY Chan, et al.. (2009). Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma. Molecular Cancer. 8(1). 120–120. 32 indexed citations

13.

Chan, Michael WY, Sandya Liyanarachchi, Curtis Balch, et al.. (2009). An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Systems Biology. 3(1). 73–73. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact